Gestational Diabetes Market Research Report, By Type (Type A1, Type A2), Administration (Oral, Intravenous), Treatment (Monitoring, Drug Treatment, Non-Pharmacological Treatment), End User (Hospital, Retail Pharmacy) - Forecast till 2032

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porters Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Gestational Diabetes Market, by Type

6.1 Introduction

6.2 Type A1

Market Estimates & Forecast, 2020 – 2027

6.3 Type A2

Market Estimates & Forecast, 2020 – 2027

6.4 Others

Market Estimates & Forecast, 2020 – 2027

Chapter 7. Global Gestational Diabetes Market, by Administration

7.1 Introduction

7.2 Oral

Market Estimates & Forecast, 2020 – 2027

7.3 Intravenous

Market Estimates & Forecast, 2020 – 2027

7.4 Others

Market Estimates & Forecast, 2020 – 2027

Chapter 8. Global Gestational Diabetes Market, by Treatment

8.1 Introduction

8.2 Monitoring

Market Estimates & Forecast, 2020 – 2027

8.2.1 Urinary Glucose Testing

8.2.2 Oral Glucose Tolerance Test

8.2.3 Others

8.3 Drug Treatment

Market Estimates & Forecast, 2020 – 2027

8.3.1 Insulin

8.3.2 Sensitizers

8.3.3 SGLT-2 Inhibitors

8.3.4 Alpha-Glucosidase Inhibitors

8.3.5 Others

8.4 Non-Pharmacological Treatment

Market Estimates & Forecast, 2020 – 2027

Chapter 9 Global Gestational Diabetes Market, by End User

9.1 Introduction

9.2 Hospitals

9.2.1 Market Estimates & Forecast, 2020 – 2027

9.3 Retail Pharmacy

9.2.2 Market Estimates & Forecast, 2020 – 2027

9.4 Others

Chapter 10. Global Gestational Diabetes Market, by Region

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 US

10.2.1.1 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

Chapter 11 Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 Novartis AG

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials

12.1.4 SWOT Analysis

12.2 Antares Pharma

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Eli Lilly

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Biocon

12.4.1 Company Overview

12.4.2 Product/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Sanofi

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.6 Abbott

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.7 AstraZeneca

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Pharmaceutical industry

Chapter 14 Appendix

LIST OF TABLES

Table 1 Gestational Diabetes Industry Synopsis, 2020 – 2027

Table 2 Global Gestational Diabetes Market Estimates and Forecast, 2020 – 2027, (USD Million)

Table 3 Global Gestational Diabetes Market by Region, 2020 – 2027, (USD Million)

Table 4 Global Gestational Diabetes Market by Types, 2020 – 2027, (USD Million)

Table 5 Global Gestational Diabetes Market by Administration, 2020 – 2027, (USD Million)

Table 6 Global Gestational Diabetes Market by Treatment, 2020 – 2027, (USD Million)

Table 7 Global Gestational Diabetes Market by End Users, 2020 – 2027, (USD Million)

Table 8 North America Gestational Diabetes Market by Types, 2020 – 2027, (USD Million)

Table 9 North America Gestational Diabetes Market by Administration, 2020 – 2027, (USD Million)

Table 10 North America Gestational Diabetes Market by Treatment, 2020 – 2027, (USD Million)

Table 11 North America Gestational Diabetes Market by End Users, 2020 – 2027, (USD Million)

Table 12 US Market by Types, 2020 – 2027, (USD Million)

Table 13 US Gestational Diabetes Market by Administration, 2020 – 2027, (USD Million)

Table 14 US Gestational Diabetes Market by Treatment, 2020 – 2027, (USD Million)

Table 15 US Gestational Diabetes Market by End Users, 2020 – 2027, (USD Million)

Table 16 Canada Market by Types, 2020 – 2027, (USD Million)

Table 17 Canada Gestational Diabetes Market by Administration, 2020 – 2027, (USD Million)

Table 18 Canada Gestational Diabetes Market by Treatment, 2020 – 2027, (USD Million)

Table 19 Canada Gestational Diabetes Market by End Users, 2020 – 2027, (USD Million)

Table 20 South America Market by Types, 2020 – 2027, (USD Million)

Table 21 South America Gestational Diabetes Market by Administration, 2020 – 2027, (USD Million)

Table 22 South America Gestational Diabetes Market by Treatment, 2020 – 2027, (USD Million)

Table 23 South America Gestational Diabetes Market by End Users, 2020 – 2027, (USD Million)

Table 24 Europe Market by Types, 2020 – 2027, (USD Million)

Table 25 Europe Gestational Diabetes Market by Administration, 2020 – 2027, (USD Million)

Table 26 Europe Gestational Diabetes Market by Treatment, 2020 – 2027, (USD Million)

Table 27 Europe Gestational Diabetes Market by End Users, 2020 – 2027, (USD Million)

Table 28 Western Europe Market by Types, 2020 – 2027, (USD Million)

Table 29 Western Europe Gestational Diabetes Market by Administration, 2020 – 2027, (USD Million)

Table 30 Western Europe Gestational Diabetes Market by Treatment, 2020 – 2027, (USD Million)

Table 31 Western Europe Gestational Diabetes Market by End Users, 2020 – 2027, (USD Million)

Table 32 Eastern Europe Market by Types, 2020 – 2027, (USD Million)

Table 33 Eastern Europe Gestational Diabetes Market by Administration, 2020 – 2027, (USD Million)

Table 34 Eastern Europe Gestational Diabetes Market by Treatment, 2020 – 2027, (USD Million)

Table 35 Eastern Europe Gestational Diabetes Market by End Users, 2020 – 2027, (USD Million)

Table 36 Asia Pacific Market by Types, 2020 – 2027, (USD Million)

Table 37 Asia Pacific Gestational Diabetes Market by Administration, 2020 – 2027, (USD Million)

Table 38 Asia Pacific Gestational Diabetes Market by Treatment, 2020 – 2027, (USD Million)

Table 39 Asia Pacific Gestational Diabetes Market by End Users, 2020 – 2027, (USD Million)

Table 40 Middle East & Africa Market by Types, 2020 – 2027, (USD Million)

Table 41 Middle East & Africa Gestational Diabetes Market by Administration, 2020 – 2027, (USD Million)

Table 42 Middle East & Africa Gestational Diabetes Market by Treatment, 2020 – 2027, (USD Million)

Table 43 Middle East & Africa Gestational Diabetes Market by End Users, 2020 – 2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Gestational Diabetes Market

Figure 3 Segmentation Market Dynamics for Global Gestational Diabetes Market

Figure 4 Global Gestational Diabetes market Share, by Type 2020

Figure 5 Global Gestational Diabetes market Share, by Administration 2020

Figure 6 Global Gestational Diabetes market Share, by Treatment 2020

Figure 7 Global Gestational Diabetes Market Share, by End Users, 2020

Figure 8 Global Gestational Diabetes Market Share, by Region, 2020

Figure 9 North America Gestational Diabetes Market Share, by Country, 2020

Figure 10 Europe Gestational Diabetes Market Share, by Country, 2020

Figure 11 Asia Pacific Gestational Diabetes Market Share, by Country, 2020

Figure 12 Middle East & Africa Gestational Diabetes Market Share, by Country, 2020

Figure 13 Global Gestational Diabetes Market: Company Share Analysis, 2020 (%)

Figure 14 Novartis AG: Key Financials

Figure 15 Novartis AG: Segmental Revenue

Figure 16 Novartis AG: Geographical Revenue

Figure 17 Antares Pharma: Key Financials

Figure 18 Antares Pharma: Segmental Revenue

Figure 19 Antares Pharma: Geographical Revenue

Figure 20 Eli Lilly: Key Financials

Figure 21 Eli Lilly: Segmental Revenue

Figure 22 Eli Lilly: Geographical Revenue

Figure 23 Biocon: Key Financials

Figure 24 Biocon: Segmental Revenue

Figure 25 Biocon: Geographical Revenue

Figure 26 Sanof: Key Financials

Figure 27 Sanofi: Segmental Revenue

Figure 28 Sanofi: Geographical Revenue

Figure 29 Abbott: Key Financials

Figure 30 Abbott: Segmental Revenue

Figure 31 Abbott: Geographical Revenue

Figure 32 AstraZeneca: Key Financials

Figure 33 AstraZeneca: Segmental Revenue

Figure 34 AstraZeneca: Geographical Revenue